Transcriptional regulation of Alzheimer's disease genes: Implications for susceptibility

Human Molecular Genetics

Volumn 9, Issue 16 REV. ISS., 2000, Pages 2383-2394

  Theuns, J ^a   Van Broeckhoven, C ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; COMPLEMENTARY DNA; CYTOSINE; GUANINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PRESENILIN 1; PRESENILIN 2; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR;

AGING; ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RAT; REVIEW; TATA BOX; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0033753842     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.16.2383     Document Type: Review

References (207)

1. Epidemiology of Alzheimer's disease
2. Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings
3. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
4. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
5. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
6. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease
7. Identification and differential expression of a novel alternative splice isoform of the βA4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells
8. βA4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons
9. Genomic organization of the human amyloid β-protein precursor gene
10. Cleavage of amyloid β peptide during constitutive processing of its precursor
11. Increased expression of β-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage
12. Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence
13. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons
14. Evidence that the 42- and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different protease activities
15. The carboxyl termini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities
16. Seeding 'one-demensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
17. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Ā42(43)
18. Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid β protein (Aβ) only in the form of Aβ 42(43)
19. Amyloid β protein (Aβ) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43)
20. Amyloid, the presenilins and Alzheimer disease
21. The role of APP processing and trafficking pathways in the formation of amyloid β-protein
22. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease
23. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3
24. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease
25. A familial Alzheimer's disease locus on chromosome 1
26. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
27. Protein topology of presenilin 1
28. Membrane topology of the C.elegans SEL-12 presenilin
29. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins
30. Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins
31. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
32. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
33. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
34. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins
35. Increased plasma amyloid β protein 1-42 levels in Down syndrome
36. Enhancement of amyloid β42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease
37. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
38. Mutant presenilin 2 transgenic mouse: Effect on an age-dependent increase of amyloid β-protein 42 in the brain
39. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
40. Amyloid β protein aβ deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ42(43)
41. A novel presenilin-1 mutation: Increased β-amyloid and neurofibrillary changes
42. Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutations
43. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
44. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos
45. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression
46. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells
47. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family
48. Presenilins are processed by caspase-type proteases
49. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression
50. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene
51. Skeletal and CNS defects in presenilin-1-deficient mice
52. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm
53. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
54. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease
55. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease
56. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
57. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage
58. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study
59. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
60. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
61. Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ε3 but not type ε4 isoform of native apolipoprotein E
62. Genetic susceptibility to Alzheimer disease
63. Confirmation that the apolipoprotein E, E4 allele is associated with late onset, familial Alzheimer's disease
64. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations
65. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
66. Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease
67. A full genome scan for late onset Alzheimer's disease
68. Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample
69. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression
70. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease
71. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
72. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
73. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
74. Localization of amyloid bβ protein messenger RNA in brains from patients with Alzheimer's disease
75. Neuronal localization of amyloid β protein precursor mRNA in normal human brain and in Alzheimer's disease
76. Alzheimer's disease amyloidogenic glycoprotein: Expression pattern in rat brain suggests a role in cell contact
77. Localization of the putative precursor of Alzheimer's disease-specific amyloid at nuclear envelopes of adult human muscle
78. Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain
79. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells
80. Fibroblast growth factor induces β-amyloid precursor mRNA in glial but not neuronal cultured cells
81. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1
82. Promoter activity of the gene encoding the β-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1
83. Retinoic acid induced differentiated neuroblastoma cells show increased expression of the βA4 amyloid gene of Alzheimer's disease and an altered splicing pattern
84. Induction of β-amyloid precursor protein isoform mRNAs by bFGF in astrocytes
85. Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes
86. Increased gene expression of Alzheimer disease β-amyloid precursor protein in senescent cultured fibroblasts
87. Transcriptional activation of Alzheimer's β-amyloid precursor protein gene by stress
88. Heat shock factor-1 mediates the transcriptional activation of Alzheimer's β-amyloid precursor protein gene in response to stress
89. Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells
90. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage
91. Increased levels of the Kunitz protease inhibitor-containing β APP mRNAs in rat brain following neurotoxic damage
92. Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice
93. Structural features of the 5' upstream regulatory region of the gene encoding rat amyloid precursor protein
94. Positive and negative regulatory elements for the expression of the Alzheimer's disease amyloid precursor-encoding gene in mouse
95. Characterization of the 5'-end region and the first two exons of the β-protein precursor gene
96. Molecular analysis of the promoter region of the gene encoding the β-amyloid precursor protein
97. The promoter of Alzheimer's disease amyloid A4 precursor gene
98. The promoter activity of the gene encoding Alzheimer β-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences
99. The amyloid β-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain
100. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter
101. The initiator element and proximal upstream sequences affect transcriptional activity and start site selection in the amyloid β-protein precursor promoter
102. Two nuclear factor binding domains activate expression from the human amyloid β-protein precursor promoter
103. The zinc finger protein CTCF binds to the APBβ domain of the amyloid β-protein precursor promoter. Evidence for a role in transcriptional activation
104. Overlapping binding sites of two different transcription factors in the promoter of the human gene for the Alzheimer amyloid precursor protein
105. The upstream stimulatory factor functionally interacts with the Alzheimer amyloid β-protein precursor gene
106. USF binds to the APBα sequence in the promoter of the amyloid β-protein precursor gene
107. Enhancer function and novel DNA binding protein activity in the near upstream βAPP gene promoter
108. Identification and characterization of a κB/Rel binding site in the regulatory region of the amyloid precursor protein gene
109. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures
110. An region upstream of the gene promoter for the β-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells
111. Promoter activity of the β-amyloid precursor protein gene is negatively modulated by an upstream regulatory element
112. Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid β protein precursor
113. Complementary DNA for the mouse homolog of the human amyloid β protein precursor
114. Functional identification of the promoter of the gene encoding the Rhesus monkey β-amyloid precursor protein
115. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
116. Cloning and characterization of the presenilin-2 gene promoter
117. Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain
118. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells
119. Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains
120. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues
121. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: Double-labeling immunohistochemical study
122. Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
123. Regional and cellular localization of presenilin-2 RNA in rat and human brain
124. Immunoreactivity of presenilin-1 in human, rat and mouse brain
125. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease
126. Neuronal expression and intracellular localization of presenilins in normal and Alzheimer disease brains
127. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain
128. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families
129. Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer's disease
130. Transcriptional regulation of the mouse presenilin-1 gene
131. An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene
132. Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: Regulatory role for the protooncogene ETS1
133. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis
134. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain
135. Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer's disease gene
136. Structure and alternative splicing of the presenilin-2 gene
137. Transcription from a TATA-less promoter requires a multisubunit TFIID complex
138. Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro
139. The apolipoprotein gene family: Organization of upstream elements and regulation of gene expression
140. Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements
141. Nucleotide sequence and structure of the human apolipoprotein E gene
142. Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors
143. Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene
144. Characterization of an upstream regulatory element of the human apolipoprotein E gene, and purification of its binding protein from the human placenta
145. Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells
146. Astrocyte cell lineage. V. Similarity of astrocytes that form in the presence of dBcAMP in cultures to reactive astrocytes in vivo
147. Transient increase in intracellular concentration of adenosine 3':5'-cyclic monophosphate results in morphological and biochemical differentiation of C6 glioma cells in culture
148. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers
149. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP
150. Downstream regulatory elements stimulate expression of the human apolipoprotein E gene in the liver and suppress expression in the kidney of transgenic mice
151. In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice
152. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice
153. A fardownstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice
154. Structure of the hepatic control region of the human apolipoprotein E/C- I gene locus
155. Structure and expression of mouse apolipoprotein E gene
156. Structure and expression of the rat apolipoprotein E gene
157. Complete nucleotide sequence of the gene encoding the rat apolipoprotein E
158. Screening for mutations in the open reading frame and promoter of the β-amyloid precursor protein gene in familial Alzheimer's disease: Identification of a further family with APP717 Val→Ile
159. Screening of the promoter and the β-amyloid sequence of the APP gene for polymorphisms in families with late onset Alzheimer's disease
160. Analysis of the c-fos gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial Alzheimer's disease
161. No evidence that common allelic variation in the Amyloid precursor protein (APP) gene confers susceptibility to Alzheimer's disease
162. DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer's disease presenilin-1 gene: Two novel mutations
163. Broeckhoven C. Variable neuron-specific presenilin 1 transcription increases risk for Alzheimer's disease
164. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele
165. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: Independent risk and linkage disequilibrium with the known APOE polymorphism
166. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease
167. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population
168. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals
169. Apolipoprotein E promoter and α2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease
170. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: Risk factors for Alzheimer's dementia?
171. Apolipoprotein E and α-1 antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
172. The -491A/T polymorphism of the apolipoprotein E gene is associated with the ApoEε4 allele and Alzheimer's disease
173. Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe
174. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world
175. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
176. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease
177. In situ hybridization of nucleus basalis neurons shows increased β-amyloid mRNA in Alzheimer disease
178. Expression of neuronal mRNAs in Alzheimer type degeneration of the nervous system
179. Increasing amyloid peptide precursor production and its impact on Alzheimer's disease
180. Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease
181. Distribution of precursor amyloid-β-protein messenger RNA in human cerebral cortex: Relationship to neurofibrillary tangles and neuritic plaques
182. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease
183. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene
184. Sp1 can displace GHF-1 from its distal binding site and stimulate transcription from the growth hormone gene promoter
185. Competition for overlapping sites in the regulatory region of the Drosophila gene Kruppel
186. Developmental expression of Sp1 in the mouse
187. SV40 stimulates expression of the transacting factor Sp1 at the mRNA level
188. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase
189. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains
190. Neuronal expression of STM2 mRNA in human brain is reduced in Alzheimer's disease
191. Injury induces presenilin-1 gene expression in mouse brain
192. Antisense-induced reduction of presenilin 1 expression selectively increases the production of amyloid β42 in transfected cells
193. Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases
194. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
195. Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro
196. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system
197. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
198. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve
199. Expression of apolipoprotein E during nerve degeneration and regeneration
200. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells
201. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
202. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
203. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes
204. A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency
205. Conserved elements in the 5' regulatory region of the amyloid precursor protein gene in primates
206. Characterization of an upstream regulatory sequence and its binding protein in the mouse apolipoprotein E gene
207. Determination of the genomic organization of human presenilin 1 by fiber-FISH analysis and restriction mapping of cloned DNA